trending Market Intelligence /marketintelligence/en/news-insights/trending/ulPdLfrBthyqyXrqnOZsrA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Miraki Innovation debuts $175M medtech fund


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Standar Baru Penilaian Pembiayaan Proyek oleh Bank


Banking Essentials Newsletter: May Edition

Miraki Innovation debuts $175M medtech fund

Technology investment and development firm Miraki Innovation introduced the $175 million Medical Technology Breakthrough Fund.

The firm said it will use the fund's capital to finance and build the next generation of innovative medical technology companies.

Cambridge, Mass.-based Miraki was formed by Christopher Velis to identify and transform medical breakthroughs into companies with substantial investor returns. Velis co-founded surgical robotics company Auris Health Inc., which was bought by Johnson & Johnson in what was considered the largest venture-funded transaction in medtech history, Miraki said.